Cnbx Pharmaceuticals Inc.
About
0.00USD+0.00 +0.00%
Closed • Updated at 04:45 GMT+00:00Market Cap$245.2K
Volume5.57M
Beta1.66
RSI47.24
Cnbx Pharmaceuticals Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
Nov 8 2022
CNBX to Enter the Cancer Immunotherapy Market After Acquiring a Controlling Interest in TaGeza Biopharma
Oct 18 2022
CNBX Files New PCT Patent Application For Cannabinoids-Based Neoadjuvant Cancer Therapy
Oct 13 2022
CNBX Patent Application "Composition and Method for Treating Cancer with Cannabinoids" Enters National Phase in US and Israel
Sep 29 2022
CNBX Peer-reviewed Study: "Possible Future Therapeutic Value" for CNBX Proprietary Drug Candidate
Sep 28 2022
CNBX Pharmaceuticals Announces New Patent Granted in Australia
Recent Videos
CNBX Pharmaceuticals: My Insight on Their $45K Loan & Cash Flow
Mar 21, 2026
CNBX Pharmaceuticals Inc. 2026 quarterly report
Jan 15, 2026
Cannabis Aktie CNBX Pharmaceuticals
Nov 12, 2022
Cannabics Pharmaceuticals Inc. (OTCQB: CNBX) | SNN Network
Jun 21, 2019
Community Chat
Ask AI
Try asking